Skip to main content

Overweight/Obesity: Metabolic Benefits to Reduce Stone Risk

  • Chapter
  • First Online:
Nutrition Therapy for Urolithiasis

Abstract

Obesity, defined by the World Health Organization (WHO) as a BMI >30 kg/m2, is considered an epidemic in the United States and is estimated to afflict >20% of the population with nearly 11.5 million people affected nationwide (Demaria and Jamal, Gastroenterol Clin N Am 34(1):127–142, 2005). The population of overweight individuals (BMI between 25 and 30 kg/m2) is likewise increasing with as many as 40 million people affected. In fact, recent analysis would suggest that approximately two-thirds of the US population is overweight or obese (Yang and Colditz, JAMA Intern Med 175:1412–1413, 2015). Worldwide there has been an exponential increase in obesity with some countries reporting a near tripling of the rate of the obese population. The association between obesity and urolithiasis is well studied, and obesity has been demonstrated to be an independent risk factor for stone disease. This chapter will aim to describe the association between overweight/obesity and biochemical characteristics associated with stone disease in this particular group of individuals. We will also discuss nutritional therapies that decrease the risk of stone recurrence, improve 24-h urinary parameters, and are utilized to decrease weight and improve other comorbidities associated with the obese/overweight patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Demaria EJ, Jamal MK. Surgical options for obesity. Gastroenterol Clin N Am. [Comparative Study Review]. 2005;34(1):127–42.

    Article  Google Scholar 

  2. Yang L, Colditz GA. Prevalence of overweight and obesity in the United States, 2007–2012. JAMA Intern Med. 2015;175:1412–3.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Swinburn BA, Caterson I, Seidell JC, James WP. Diet, nutrition and the prevention of excess weight gain and obesity. Public Health Nutr. 2004 Feb;7(1A):123–46.

    CAS  PubMed  Google Scholar 

  4. Must A, Spadano J, Coakley EH, Field AE, Colditz G, Dietz WH. The disease burden associated with overweight and obesity. JAMA. [Research Support, Non-U.S. Gov’t]. 1999;282(16):1523–9.

    Article  CAS  PubMed  Google Scholar 

  5. Popkin BM. The nutrition transition and obesity in the developing world. J Nutr. [Review]. 2001;131(3):871S–3S.

    CAS  PubMed  Google Scholar 

  6. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293(4):455–62.

    Article  CAS  PubMed  Google Scholar 

  7. Taylor EN, Curhan GC. Body size and 24-hour urine composition. Am J Kidney Dis. [Research Support, N.I.H., Extramural]. 2006;48(6):905–15.

    Article  CAS  PubMed  Google Scholar 

  8. Torricelli FC, De S, Li I, Sarkissian C, Monga M. Can obese stone formers follow dietary recommendations? J Endourol. 2014;28(2):248–51.

    Article  PubMed  Google Scholar 

  9. Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. [Clinical Trial Randomized Controlled Trial]. 1996;155(3):839–43.

    Article  CAS  PubMed  Google Scholar 

  10. Borghi L, Meschi T, Amato F, Novarini A, Romanelli A, Cigala F. Hot occupation and nephrolithiasis. J Urol. 1993;150(6):1757–60.

    Article  CAS  PubMed  Google Scholar 

  11. Fink HA, Akornor JW, Garimella PS, MacDonald R, Cutting A, Rutks IR, et al. Diet, fluid, or supplements for secondary prevention of nephrolithiasis: a systematic review and meta-analysis of randomized trials. Eur Urol. [Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, Non-P.H.S. Review]. 2009;56(1):72–80.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Shuster J, Jenkins A, Logan C, Barnett T, Riehle R, Zackson D, et al. Soft drink consumption and urinary stone recurrence: a randomized prevention trial. J Clin Epidemiol. [Clinical Trial Randomized Controlled Trial Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. 1992;45(8):911–6.

    Article  CAS  PubMed  Google Scholar 

  13. Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K. The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int. [Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.]. 2004;65(2):386–92.

    Article  CAS  PubMed  Google Scholar 

  14. Sakhaee K, Adams-Huet B, Moe OW, Pak CY. Pathophysiologic basis for normouricosuric uric acid nephrolithiasis. Kidney Int. [Comparative Study Research Support, U.S. Gov’t, Non-P.H.S. Research Support, U.S. Gov’t, P.H.S.]. 2002;62(3):971–9.

    Article  CAS  PubMed  Google Scholar 

  15. Sakhaee K, Maalouf NM. Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol. [Research Support, N.I.H., Extramural Review]. 2008;28(2):174–80.

    Article  CAS  PubMed  Google Scholar 

  16. Siener R, Glatz S, Nicolay C, Hesse A. The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004;12(1):106–13.

    Article  CAS  PubMed  Google Scholar 

  17. Grover PK, Marshall VR, Ryall RL. Dissolved urate salts out calcium oxalate in undiluted human urine in vitro: implications for calcium oxalate stone genesis. Chem Biol. 2003;10(3):271–8.

    Article  CAS  PubMed  Google Scholar 

  18. Rendina D, De Filippo G, Zampa G, Muscariello R, Mossetti G, Strazzullo P. Characteristic clinical and biochemical profile of recurrent calcium-oxalate nephrolithiasis in patients with metabolic syndrome. Nephrol Dial Transplant. 2011;26(7):2256–63.

    Article  CAS  PubMed  Google Scholar 

  19. Wrobel BM, Schubert G, Hormann M, Strohmaier WL. Overweight and obesity: risk factors in calcium oxalate stone disease? Adv Urol. 2012;2012:438707.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol. [Research Support, Non-U.S. Gov’t]. 2008;179(2):570–4.

    Article  PubMed  Google Scholar 

  21. Shavit L, Ferraro PM, Johri N, Robertson W, Walsh SB, Moochhala S, et al. Effect of being overweight on urinary metabolic risk factors for kidney stone formation. Nephrol Dial Transplant. 2015;30(4):607–13.

    Article  CAS  PubMed  Google Scholar 

  22. Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. [Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 2010;91(3):565–70.

    Article  CAS  PubMed  Google Scholar 

  23. Alberti KG, Zimmet P, Shaw J, et al. Lancet. [Research Support, Non-U.S. Gov’t]. 2005;366(9491):1059–62.

    Article  PubMed  Google Scholar 

  24. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. [Review]. 2006;21(1):1–6.

    Article  PubMed  Google Scholar 

  25. Wong YV, Cook P, Somani BK. The association of metabolic syndrome and urolithiasis. Int J Endocrinol Print. [Review]. 2015;2015:570674.

    Google Scholar 

  26. Kohjimoto Y, Sasaki Y, Iguchi M, Matsumura N, Inagaki T, Hara I. Association of metabolic syndrome traits and severity of kidney stones: results from a nationwide survey on urolithiasis in Japan. Am J Kidney Dis: Off J Nat Kidney Found. [Research Support, Non-U.S. Gov’t]. 2013;61(6):923–9.

    Article  Google Scholar 

  27. West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988–1994. Am J Kidney Dis: Off J Nat Kidney Found. 2008;51(5):741–7.

    Article  Google Scholar 

  28. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. 1993;328(12):833–8.

    Article  CAS  PubMed  Google Scholar 

  29. Yun SJ, Ha YS, Kim WT, Kim YJ, Lee SC, Kim WJ. Sodium restriction as initial conservative treatment for urinary stone disease. J Urol. [Research Support, Non-U.S. Gov’t]. 2010;184(4):1372–6.

    Article  CAS  PubMed  Google Scholar 

  30. Weinberg AE, Patel CJ, Chertow GM, Leppert JT. Diabetic severity and risk of kidney stone disease. Eur Urol. 2014;65(1):242–7.

    Article  PubMed  Google Scholar 

  31. Kocvara R, Plasgura P, Petrik A, Louzensky G, Bartonickova K, Dvoracek J. A prospective study of nonmedical prophylaxis after a first kidney stone. BJU Int. [Clinical Trial Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov’t]. 1999;84(4):393–8.

    Article  CAS  PubMed  Google Scholar 

  32. Ortiz-Alvarado O, Miyaoka R, Kriedberg C, Moeding A, Stessman M, Anderson JK, et al. Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers. J Endourol. 2011;25(3):535–40.

    Article  PubMed  Google Scholar 

  33. Escribano J, Balaguer A, Roque i Figuls M, Feliu A, Ferre N. Dietary interventions for preventing complications in idiopathic hypercalciuria. Cochrane Database Syst Rev. [Research Support, Non-U.S. Gov’t Review]. 2014;2:CD006022.

    Google Scholar 

  34. Wertheim ML, Nakada SY, Penniston KL. Current practice patterns of urologists providing nutrition recommendations to patients with kidney stones. J Endourol. 2014;28(9):1127–31.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcelino E. Rivera MD .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rivera, M.E., Krambeck, A.E. (2018). Overweight/Obesity: Metabolic Benefits to Reduce Stone Risk. In: Lowry, P., Penniston, K. (eds) Nutrition Therapy for Urolithiasis. Springer, Cham. https://doi.org/10.1007/978-3-319-16414-4_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16414-4_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16413-7

  • Online ISBN: 978-3-319-16414-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics